{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T11:56:16Z","timestamp":1793361376935,"version":"4.5.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.arr.2026.103230","type":"journal-article","created":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T15:04:40Z","timestamp":1783263880000},"page":"103230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The brain renin\u2013angiotensin system in Parkinson\u2019s disease: Friend or foe? mechanistic insights and therapeutic implications"],"prefix":"10.1016","volume":"121","author":[{"given":"Gursimran","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2450-2975","authenticated-orcid":false,"given":"Khadga Raj","family":"Aran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2026.103230_bib1","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.sjbs.2020.01.026","article-title":"Role of brain renin angiotensin system in neurodegeneration: an update","volume":"27","author":"Abiodun","year":"2020","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.arr.2026.103230_bib2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.nbd.2012.02.006","article-title":"Minocycline attenuates microglia activation and blocks the long-term epileptogenic effects of early-life seizures","volume":"46","author":"Abraham","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2026.103230_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102200","article-title":"The classical and non-classical axes of renin-angiotensin system in Parkinson disease: the bright and dark side of the moon","volume":"94","author":"Al-Kuraishy","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2026.103230_bib4","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18495","article-title":"The potential role of brain renin-angiotensin system in the neuropathology of Parkinson disease: Friend, foe or turncoat?","volume":"28","author":"Al-Qahtani","year":"2024","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.arr.2026.103230_bib5","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-025-05113-y","article-title":"Targeting of the PI3K\/AKT\/GSK3\u03b2 Pathway in Parkinson\u2019s Disease: a therapeutic blueprint","author":"AlRuwaili","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2026.103230_bib6","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.bja.2019.07.017","article-title":"Propranolol protects cerebral autoregulation and reduces hippocampal neuronal cell death through inhibition of interleukin-6 upregulation after traumatic brain injury in pigs","volume":"123","author":"Armstead","year":"2019","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.arr.2026.103230_bib7","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3390\/antiox14060656","article-title":"Redox imbalance in inflammation: the interplay of oxidative and reductive stress","volume":"14","author":"Bellanti","year":"2025","journal-title":"Antioxidants"},{"key":"10.1016\/j.arr.2026.103230_bib8","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.3390\/biom12101429","article-title":"Impact of the renin-angiotensin system on the pathogeny and pharmacotherapeutics of neurodegenerative diseases","volume":"12","author":"Bild","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.arr.2026.103230_bib9","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.3390\/biom12101429","article-title":"Impact of the renin-angiotensin system on the pathogeny and pharmacotherapeutics of neurodegenerative diseases","volume":"12","author":"Bild","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.arr.2026.103230_bib10","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.3390\/antiox10081238","article-title":"Angiotensin II induces oxidative stress and endothelial dysfunction in mouse ophthalmic arteries via involvement of AT1 receptors and NOX2","volume":"10","author":"Birk","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.arr.2026.103230_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/s41531-025-01230-6","article-title":"Brain-derived extracellular vesicle proteomics reveals neuroprotection induced by the ARB candesartan in Parkinson\u2019s disease patients","author":"Camacho-Me\u00f1o","year":"2025","journal-title":"npj Park. 's. Dis."},{"key":"10.1016\/j.arr.2026.103230_bib12","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.4103\/1673-5374.313061","article-title":"Potential protective role of ACE-inhibitors and AT1 receptor blockers against levodopa-induced dyskinesias: a retrospective case-control study","volume":"16","author":"Contaldi","year":"2021","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.arr.2026.103230_bib13","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1161\/CIRCRESAHA.108.176594","article-title":"The trafficking protein GABARAP binds to and enhances plasma membrane expression and function of the angiotensin II type 1 receptor","volume":"102","author":"Cook","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.arr.2026.103230_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.586314","article-title":"Brain renin\u2013angiotensin system at the intersect of physical and cognitive frailty","volume":"14","author":"Cosarderelioglu","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.arr.2026.103230_bib15","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejphar.2017.02.016","article-title":"Role of interleukin-10 in the neuroprotective effect of the Angiotensin Type 2 Receptor agonist, compound 21, after ischemia\/reperfusion injury","volume":"799","author":"Fouda","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.arr.2026.103230_bib16","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1172\/JCI87306","article-title":"Angiotensin receptors and \u03b2-catenin regulate brain endothelial integrity in malaria","volume":"126","author":"Gallego-Delgado","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.arr.2026.103230_bib17","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.4103\/1673-5374.324854","article-title":"Angiotensin-(1\u20137) reduces \u03b1-synuclein aggregation by enhancing autophagic activity in Parkinson\u2019s disease","volume":"17","author":"Gao","year":"2022","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.arr.2026.103230_bib18","doi-asserted-by":"crossref","first-page":"24099","DOI":"10.18632\/oncotarget.15732","article-title":"Azilsartan ameliorates apoptosis of dopaminergic neurons and rescues characteristic parkinsonian behaviors in a rat model of Parkinson\u2019s disease","volume":"8","author":"Gao","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.arr.2026.103230_bib19","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.1007938","article-title":"The renin-angiotensin-aldosterone system: mechanisms, pathophysiological impacts, and emerging therapeutic strategies","author":"Gong","year":"2024","journal-title":"Renin-Angiotensin-Aldosterone Syst. -Latest Trends"},{"key":"10.1016\/j.arr.2026.103230_bib20","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.brainres.2005.03.038","article-title":"Angiotensin II protects cultured midbrain dopaminergic neurons against rotenone-induced cell death","volume":"1045","author":"Grammatopoulos","year":"2005","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.arr.2026.103230_bib21","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1326-2-1","article-title":"Angiotensin type 1 receptor antagonist losartan, reduces MPTP-induced degeneration of dopaminergic neurons in substantia nigra","volume":"2","author":"Grammatopoulos","year":"2007","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2026.103230_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2019.146353","article-title":"Effects of angiotensin-II on brain endothelial cell permeability via PPARalpha regulation of para-and trans-cellular pathways","volume":"1722","author":"Guo","year":"2019","journal-title":"Brain Res."},{"key":"10.1016\/j.arr.2026.103230_bib23","doi-asserted-by":"crossref","first-page":"628","DOI":"10.52586\/4972","article-title":"The renin-angiotensin system in central nervous system tumors and degenerative diseases","volume":"26","author":"Haron","year":"2021","journal-title":"Front. Biosci. Landmark"},{"key":"10.1016\/j.arr.2026.103230_bib24","doi-asserted-by":"crossref","first-page":"7693","DOI":"10.3390\/ijms21207693","article-title":"Cannabinoid receptors: an update on cell signaling, pathophysiological roles and therapeutic opportunities in neurological, cardiovascular, and inflammatory diseases","volume":"21","author":"Haspula","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2026.103230_bib25","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/jcbfm.2013.240","article-title":"PPAR agonist-mediated protection against HIV Tat-induced cerebrovascular toxicity is enhanced in MMP-9-deficient mice","volume":"34","author":"Huang","year":"2014","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.arr.2026.103230_bib26","doi-asserted-by":"crossref","DOI":"10.1177\/00368504211054985","article-title":"Inflammatory cytokines TNF\u03b1, IL-1\u03b2, and IL-6 are induced in endotoxin-stimulated microglia through different signaling cascades","volume":"104","author":"Ishijima","year":"2021","journal-title":"Sci. Progress."},{"key":"10.1016\/j.arr.2026.103230_bib27","first-page":"S113","article-title":"Inflammasome activation in Parkinson\u2019s disease","volume":"12","author":"Jewell","year":"2022","journal-title":"J. Park. \u2019S. Dis."},{"key":"10.1016\/j.arr.2026.103230_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.837890","article-title":"Protective effect of renin-angiotensin system inhibitors on Parkinson\u2019s disease: a nationwide cohort study","volume":"13","author":"Jo","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.arr.2026.103230_bib29","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/1470320315583582","article-title":"Cerebroprotective effects of RAS inhibitors: beyond their cardio-renal actions","volume":"16","author":"Kalra","year":"2015","journal-title":"J. Renin-Angiotensin-Aldosterone Syst."},{"key":"10.1016\/j.arr.2026.103230_bib30","article-title":"A molecular census of midbrain dopaminergic neurons in Parkinson\u2019s disease","author":"Kamath","year":"2021","journal-title":"BioRxiv"},{"key":"10.1016\/j.arr.2026.103230_bib31","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/s41593-022-01061-1","article-title":"Single-cell genomic profiling of human dopamine neurons identifies a population that selectively degenerates in Parkinson\u2019s disease","volume":"25","author":"Kamath","year":"2022","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.arr.2026.103230_bib32","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/s41593-022-01061-1","article-title":"Single-cell genomic profiling of human dopamine neurons identifies a population that selectively degenerates in Parkinson\u2019s disease","volume":"25","author":"Kamath","year":"2022","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.arr.2026.103230_bib33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0009-8981(94)90259-3","article-title":"Increased angiotensin-converting enzyme activity in cerebrospinal fluid of treated patients with Parkinson\u2019s disease","volume":"231","author":"Konings","year":"1994","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.arr.2026.103230_bib34","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0024-3205(02)01772-1","article-title":"Effects of losartan on the blood\u2013brain barrier permeability in long-term nitric oxide blockade-induced hypertensive rats","volume":"71","author":"Kucuk","year":"2002","journal-title":"Life Sci."},{"key":"10.1016\/j.arr.2026.103230_bib35","article-title":"A double-blind randomized clinical trial to evaluate the effects of Candesartan for Cognitive and Neuropsychiatric Impairment in Parkinson\u2019s Disease","volume":"37","author":"Kulisevsky","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2026.103230_bib36","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41531-022-00340-9","article-title":"Angiotensin type-1 receptor and ACE2 autoantibodies in Parkinson s disease","volume":"8","author":"Labandeira","year":"2022","journal-title":"npj Park. \u2019S. Dis."},{"key":"10.1016\/j.arr.2026.103230_bib37","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40035-024-00410-3","article-title":"The role of the brain renin-angiotensin system in Parkinson s disease","volume":"13","author":"Labandeira-Garcia","year":"2024","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.arr.2026.103230_bib38","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fnagi.2017.00129","article-title":"Brain renin-angiotensin system and microglial polarization: implications for aging and neurodegeneration","volume":"9","author":"Labandeira-Garcia","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2026.103230_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2020.101919","article-title":"The intracellular renin-angiotensin system: Friend or foe. Some light from the dopaminergic neurons","volume":"199","author":"Labandeira-Garcia","year":"2021","journal-title":"Progress. Neurobiol."},{"key":"10.1016\/j.arr.2026.103230_bib40","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1002\/mds.29137","article-title":"Nigral neurons degenerating in Parkinson\u2019s disease express the angiotensin receptor type 1 gene","volume":"37","author":"Labandeira-Garcia","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2026.103230_bib41","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/S0140-6736(19)32500-0","article-title":"Fenfluramine hydrochloride for the treatment of seizures in dravet syndrome: a randomised, double-blind, placebo-controlled trial","volume":"394","author":"Lagae","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.arr.2026.103230_bib42","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41531-024-00650-0","article-title":"Angiotensin type 1 receptor activation promotes neuronal and glial alpha-synuclein aggregation and transmission","volume":"10","author":"Lage","year":"2024","journal-title":"npj Park. \u2019S. Dis."},{"key":"10.1016\/j.arr.2026.103230_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1457459","article-title":"Angiotensin type-1 receptor autoantibodies promote alpha-synuclein aggregation in dopaminergic neurons","volume":"15","author":"Lage","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.arr.2026.103230_bib44","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ntt.2014.11.004","article-title":"Angiotensin AT2 receptor stimulation inhibits activation of NADPH oxidase and ameliorates oxidative stress in rotenone model of Parkinson\u2019s disease in CATH. a cells","volume":"47","author":"Lu","year":"2015","journal-title":"Neurotoxicology Teratol."},{"key":"10.1016\/j.arr.2026.103230_bib45","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/1470320309347789","article-title":"The role of the central renin-angiotensin system in Parkinson\u2019s disease","volume":"11","author":"Mertens","year":"2010","journal-title":"J. Renin-Angiotensin-Aldosterone Syst."},{"key":"10.1016\/j.arr.2026.103230_bib46","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","article-title":"APOE4 leads to blood\u2013brain barrier dysfunction predicting cognitive decline","volume":"581","author":"Montagne","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.arr.2026.103230_bib47","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1080\/14656566.2019.1612365","article-title":"Evaluating ADS5102 (amantadine) for the treatment of Parkinson\u2019s disease patients with dyskinesia","volume":"20","author":"M\u00fcller","year":"2019","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.arr.2026.103230_bib48","first-page":"2117","article-title":"Role of NLRP3 inflammasome in Parkinson\u2019s disease and therapeutic considerations","volume":"12","author":"Nguyen","year":"2022","journal-title":"J. Park. \u2019S. Dis."},{"key":"10.1016\/j.arr.2026.103230_bib49","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neuropharm.2014.10.028","article-title":"Microglial priming and enhanced reactivity to secondary insult in aging, and traumatic CNS injury, and neurodegenerative disease","volume":"96","author":"Norden","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.arr.2026.103230_bib50","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12868-024-00876-x","article-title":"The angiotensin II receptors type 1 and 2 modulate astrocytes and their crosstalk with microglia and neurons in an in vitro model of ischemic stroke","volume":"25","author":"Olschewski","year":"2024","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.arr.2026.103230_bib51","doi-asserted-by":"crossref","DOI":"10.1177\/1470320316672349","article-title":"Mitochondrial-dependent mechanisms are involved in angiotensin II-induced apoptosis in dopaminergic neurons","volume":"17","author":"Ou","year":"2016","journal-title":"J. Renin-Angiotensin-Aldosterone Syst."},{"key":"10.1016\/j.arr.2026.103230_bib52","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bbrc.2009.04.126","article-title":"The angiotensin II\u2013AT1 receptor stimulates reactive oxygen species within the cell nucleus","volume":"384","author":"Pendergrass","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.arr.2026.103230_bib53","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bbrc.2009.04.126","article-title":"The angiotensin II\u2013AT1 receptor stimulates reactive oxygen species within the cell nucleus","volume":"384","author":"Pendergrass","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.arr.2026.103230_bib54","doi-asserted-by":"crossref","DOI":"10.1177\/2058738420974900","article-title":"Candesartan modulates microglia activation and polarization via NF-\u03baB signaling pathway","volume":"34","author":"Qie","year":"2020","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.arr.2026.103230_bib55","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3390\/antiox11020329","article-title":"Angiotensin type-1 receptor inhibition reduces NLRP3 inflammasome upregulation induced by aging and neurodegeneration in the substantia nigra of male rodents and primary mesencephalic cultures","volume":"11","author":"Quijano","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.arr.2026.103230_bib56","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3934\/Neuroscience.2023017","article-title":"Depletion of dopamine in Parkinson\u2019s disease and relevant therapeutic options: A review of the literature","volume":"10","author":"Ramesh","year":"2023","journal-title":"AIMS Neurosci."},{"key":"10.1016\/j.arr.2026.103230_bib57","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/s41531-024-00827-7","article-title":"Cannabinoid regulation of angiotensin II-induced calcium signaling in striatal neurons","volume":"10","author":"Rivas-Santisteban","year":"2024","journal-title":"npj Park. \u2019S. Dis."},{"key":"10.1016\/j.arr.2026.103230_bib58","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.nbd.2017.04.004","article-title":"Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson\u2019s disease","volume":"109","author":"Rocha","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2026.103230_bib59","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jns.2016.07.031","article-title":"Peripheral levels of angiotensins are associated with depressive symptoms in Parkinson\u2019s disease","volume":"368","author":"Rocha","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.arr.2026.103230_bib60","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.nbd.2008.03.003","article-title":"Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS","volume":"31","author":"Rodriguez-Pallares","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2026.103230_bib61","author":"Rukavina Mikusic","year":"2021","journal-title":"Ang. -(1-7) Mas Recept. brain"},{"key":"10.1016\/j.arr.2026.103230_bib62","doi-asserted-by":"crossref","first-page":"31540","DOI":"10.1074\/jbc.M112.346296","article-title":"Angiotensin II induces vascular endocannabinoid release, which attenuates its vasoconstrictor effect via CB1 cannabinoid receptors","volume":"287","author":"Szekeres","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2026.103230_bib63","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/acn3.52132","article-title":"Associations of renin\u2013angiotensin system inhibitor use with brain insulin signaling and neuropathology","volume":"11","author":"Tong","year":"2024","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.arr.2026.103230_bib64","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3390\/membranes15090263","article-title":"Mitochondria-Associated Membrane Dysfunction in Neurodegeneration and Its Effects on Lipid Metabolism, Calcium Signaling, and Cell Fate","volume":"15","author":"Truong","year":"2025","journal-title":"Membranes"},{"key":"10.1016\/j.arr.2026.103230_bib65","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.parkreldis.2021.03.007","article-title":"Effects of angiotensin type 1 receptor antagonists on Parkinson\u2019s disease progression: An exploratory study in the PPMI database","volume":"86","author":"Udovin","year":"2021","journal-title":"Park. & Relat. Disord."},{"key":"10.1016\/j.arr.2026.103230_bib66","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.327","article-title":"Mitochondrial angiotensin receptors in dopaminergic neurons. Role in cell protection and aging-related vulnerability to neurodegeneration","volume":"7","author":"Valenzuela","year":"2016","journal-title":"Cell. Death & Dis."},{"key":"10.1016\/j.arr.2026.103230_bib67","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/ajh\/hpu197","article-title":"Neuroprotective effects of angiotensin receptor blockers","volume":"28","author":"Villapol","year":"2015","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.arr.2026.103230_bib68","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-012044","article-title":"Can commonly prescribed drugs be repurposed for the prevention or treatment of alzheimer\u2019s and other neurodegenerative diseases? Protocol for an observational cohort study in the UK clinical practice research datalink","volume":"6","author":"Walker","year":"2016","journal-title":"BMJ Open."},{"key":"10.1016\/j.arr.2026.103230_bib69","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1172\/JCI31547","article-title":"Valsartan lowers brain \u03b2-amyloid protein levels and improves spatial learning in a mouse model of alzheimer disease","volume":"117","author":"Wang","year":"2007","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.arr.2026.103230_bib70","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.intimp.2018.12.019","article-title":"The mechanisms of NLRP3 inflammasome\/pyroptosis activation and their role in Parkinson\u2019s disease","volume":"67","author":"Wang","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.arr.2026.103230_bib71","article-title":"Peroxisome proliferator activated receptor-\u03b1 agonist slows the progression of hypertension, attenuates plasma interleukin-6 levels and renal inflammatory markers in angiotensin II infused mice","volume":"2012","author":"Wilson","year":"2012","journal-title":"PPAR Res."},{"key":"10.1016\/j.arr.2026.103230_bib72","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3389\/fendo.2013.00158","article-title":"A role for the brain RAS in Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"4","author":"Wright","year":"2013","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.arr.2026.103230_bib73","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s13760-024-02560-7","article-title":"Renin-angiotensin system inhibitor use and risk of Parkinson\u2019s disease: a meta-analysis","volume":"125","author":"Xu","year":"2025","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.arr.2026.103230_bib74","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40478-015-0189-z","article-title":"Loss of angiotensin II receptor expression in dopamine neurons in Parkinson\u2019s disease correlates with pathological progression and is accompanied by increases in Nox4-and 8-OH guanosine-related nucleic acid oxidation and caspase-3 activation","volume":"3","author":"Zawada","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.arr.2026.103230_bib75","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1016\/j.sjbs.2021.02.029","article-title":"Correlation between serum renin-angiotensin system (RAS) level and depression and anxiety symptoms in patients with Parkinson's disease","volume":"28","author":"Zhao","year":"2021","journal-title":"Saudi J. Biol. Sci."}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163726002229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163726002229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T12:04:40Z","timestamp":1787659480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163726002229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":75,"alternative-id":["S1568163726002229"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2026.103230","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The brain renin\u2013angiotensin system in Parkinson\u2019s disease: Friend or foe? mechanistic insights and therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2026.103230","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103230"}}